1996
DOI: 10.1177/009286159603000321
|View full text |Cite
|
Sign up to set email alerts
|

Preparing Modular Labeling Information for Pharmaceuticals and Radiopharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
1998
1998

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…However, the label design parameters that affect perceptions of claim effectiveness are not fully understood. Basic regulations in the U.S., Europe and Canada require labels to contain basic information such as the disease or symptoms targeting by the product, and any contraindications or side effects (Gans et al, 1996). Grisaffe and Shellabarger (1997) found a direct link between label contents and perceptions of efficacy and intentions to purchase.…”
Section: Introductionmentioning
confidence: 99%
“…However, the label design parameters that affect perceptions of claim effectiveness are not fully understood. Basic regulations in the U.S., Europe and Canada require labels to contain basic information such as the disease or symptoms targeting by the product, and any contraindications or side effects (Gans et al, 1996). Grisaffe and Shellabarger (1997) found a direct link between label contents and perceptions of efficacy and intentions to purchase.…”
Section: Introductionmentioning
confidence: 99%